Diagnosis and monitoring of acute rejection after lung transplantation
Diagnosis and monitoring of acute rejection after lung transplantation
批准号:
17591469
负责人:
MINAMI Masato
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
肺移植术后急性期对急性排斥反应、再灌注损伤或肺部感染的准确诊断是困难的。我们探讨了流式细胞术检测外周血淋巴细胞表面抗原(CD3, CD4, CD8, CD25, CD69, CD45RA, CD45RO)的临床应用,以诊断移植后患者的状态。并讨论了抗cd25抗体的作用。我们发现病程稳定的患者CD4/CD8比值、CD25表达、CD69表达及CD45RA/RO比例无明显变化。CD28表达水平在移植后1个月内下降,与CD4亚群相比,这种趋势主要发生在CD8 T细胞中。间质性肺炎患者CD4 T细胞中CD25表达升高,CD8 T细胞中CD69表达升高。CD25抗体可抑制CD25的表达。
英文摘要
Accurate diagnosis of acute rejection, reperfusion injury, or pulmonary infection is difficult in the postoperative acute phase in the lung transplantation. We investigate the clinical utility of flow cytometry for surface antigen (CD3, CD4, CD8, CD25, CD69, CD45RA, CD45RO) on peripheral blood lymphocytes in order to diagnose the posttransplant status of patients. Also, the effect of anti-CD25 antibody administration was discussed. We found no evident change of CD4/CD8 ratio, CD25 expression, CD69 expression, and the proportion of CD45RA/RO in the patient with stable course. CD28 expression level decreased during the 1st month after transplant and this tendency was predominantly found in CD8 T cells as compared to CD4 subset. In a patient suffering interstitial pneumonia, increase of CD25 expression in CD4 T cells and increase of CD69 expression in CD8 T cells were shown. CD25 expression might be suppressed by CD25 antibody administration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Trial of the pulmonary ischemic re-perfusion injury suppression by the suppression of the mitochondrial injury
-
批准号:22591565
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.83万
-
财政年份:2010
-
负责人:MINAMI Masato
-
依托单位:
Investigation of factors affecting fitness based on long-term studyfor individually recognized large mammals.
-
批准号:22570030
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.25万
-
财政年份:2010
-
负责人:MINAMI Masato
-
依托单位:
Novel treatment strategy for the chronic emphysema aiming for regeneration of the lung by collaboration between medicine and engineering research.
-
批准号:19591624
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:MINAMI Masato
-
依托单位:
Research on earth-and-sand control of the artificial reef installed near the mouth of a river
-
批准号:18560506
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.03万
-
财政年份:2006
-
负责人:MINAMI Masato
-
依托单位:
Research for the Opening width and End process on the artificial reefs
-
批准号:15560449
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$0.96万
-
财政年份:2003
-
负责人:MINAMI Masato
-
依托单位:
Possibility of sequential transplantation of brain-dead donor single lung and contralateral living-donor lobe
-
批准号:14571264
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2002
-
负责人:MINAMI Masato
-
依托单位:
Gene therapy in lung transplantation. Attenuation of ischemia/reperfusion injury and acute rejection by NF-kB decoy transfection
-
批准号:12671307
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2000
-
负责人:MINAMI Masato
-
依托单位:
Role of Chemokines in Acute Rejection after Rat Lung Transplantation. Interaction with Nitric Oxide and Endothelin.
-
批准号:10671257
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.98万
-
财政年份:1998
-
负责人:MINAMI Masato
-
依托单位:
Analyses of the process to the chronic rejection after rat lung trasplantation.
-
批准号:07671466
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1995
-
负责人:MINAMI Masato
-
依托单位:
国内基金
海外基金
登录
查看更多内容
TLR2影响角膜移植术后植片转归的机制研究
-
批准号:81170887
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2011
-
负责人:白浪
-
依托单位:
新城疫病毒重组异源基因疫苗特异性抗肿瘤研究
-
批准号:81172139
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2011
-
负责人:赵永祥
-
依托单位:
Endoglin适配体靶向异源基因疫苗抗肿瘤研究
-
批准号:81072161
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2010
-
负责人:赵永祥
-
依托单位:
MICA基因及其抗体在肾移植排斥反应中的作用机制与干预策略研究
-
批准号:30872530
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2008
-
负责人:侯建全
-
依托单位:
超急性排斥反应靶向抗肿瘤自杀基因疫苗的研究
-
批准号:30660185
-
项目类别:地区科学基金项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:赵永祥
-
依托单位: